CLINICAL_TRIALS ClinicalTrials.gov record update

Phase IIb Primary Vaccination Study to Evaluate Non-Inferiority & Persistence of the Immune Response of GSK Biologicals' MenACWY Conjugate Vaccine (Intramuscularly) vs Mencevax ACWY (Subcutaneously) to Healthy Subjects (11-55 Years of Age)

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT00356369
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:36:53.351147+00:00
Published At: 2018-06-04T00:00:00+00:00
Record Updated At: 2018-07-03
Results Posted At: 2018-06-04
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Infections, Meningococcal"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2018-07-03"
protocolSection.identificationModule.nctId: "NCT00356369"
protocolSection.identificationModule.officialTitle: "Phase IIb Primary Vaccination Study to Evaluate Non-Inferiority \u0026 Persistence of the Immune Response of GSK Biologicals\u0027 MenACWY Conjugate Vaccine (Intramuscularly) vs Mencevax ACWY (Subcutaneously) to Healthy Subjects (11-55 Years of Age)"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2018-06-04"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.